Search results
Results from the WOW.Com Content Network
PDL BioPharma (PDLI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
PDLI earnings call for the period ending March 31, 2019.
PDL BioPharma (PDLI) is an inspired choice for value investors, as it is hard to beat its incredible lineup of statistics on this front.
[2] [3] In 2008 in response to shareholder pressure, PDL spun out its active development programs to a company called Facet Biotech that it capitalized with $400 million. [ 4 ] [ 5 ] Protein Design Labs, founded in 1986 [ 5 ] by cell biologist Laurence J. Korn and mathematician Cary Queen, [ 6 ] was a pioneer in humanizing monoclonal antibodies .
The big shareholder groups in PDL BioPharma, Inc. (NASDAQ:PDLI) have power over the company. Institutions often own...
For premium support please call: 800-290-4726 more ways to reach us
For premium support please call: 800-290-4726 more ways to reach us
Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, antibody humanization patent manager PDL BioPharma (NAS: PDLI ...